1. Mc Steinhoff, K. Edwards, H. Keyserling, C. Johnson, D. Madore, D. Hogerman, Immunogenicity and safety of 3 bivalent S pneumoniae conjugate vaccines in young children (Program and Abstracts of the 32nd Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington DC; 1992 325).
2. Considerations for formulating the second-generation pneumococcal capsular polysaccharide vaccine with emphasis on the cross-reactive types within groups;Robbins;J Infect Dis,1983
3. New vaccine development: establishing priorities. Vol II. Diseases of importance in developing countries;Institute of Medicine,1986
4. Pneumococcal vaccine trials in Papua New Guinea: relationships between epidemiology of pneumococcal infection and efficacy of vaccine;Riley;Rev Infect Dis,1991
5. Antimicrobial resistance of pneumococci in children with acute lower respiratory tract infection in Pakistan;Mastro;Lancet,1991